Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: Findings from the adjuvant colon cancer endpoints data set

Journal of Clinical Oncology

Volumn 30, Issue 19, 2012, Pages 2334-2339

  Hubbard, Joleen ^a   Thomas, David M ^b   Yothers, Greg ^c,d   Green, Erin ^a   Blanke, Charles ^e   O'Connell, Michael J ^c   Labianca, Roberto ^f   Shi, Qian ^a   Bleyer, Archie ^g   De Gramont, Aimery ^h   Sargent, Daniel ^a  

^a MAYO CLINIC   (United States)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c NSABP Foundation Inc   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f OSPEDALI RIUNITI   (Italy)

^g St Charles Health System   (United States)

^h HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; OXALIPLATIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CLINICAL EFFECTIVENESS; COLON CANCER; DELAYED DIAGNOSIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SURVIVAL RATE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE III AS TOPIC; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84863993416     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.41.1975     Document Type: Article

References (20)

1. Jemal A, Siegel R, Xu J, et al: Cancer statistics, 2010. CA Cancer J Clin 60:277-300, 2010
2. Bleyer A, Choi M, Fuller CD, et al: Relative lack of conditional survival improvement in young adults with cancer. Semin Oncol 36:460-467, 2009
3. Bleyer A, Budd T, Montello M: Adolescents and young adults with cancer: The scope of the problem and criticality of clinical trials. Cancer 107:1645-1655, 2006 (Pubitemid 44537071)
4. Bleyer A: The adolescent and young adult gap in cancer care and outcome. Curr Probl Pediatr Adolesc Health Care 35:182-217, 2005
5. National Cancer Institute, and the LiveStrong Young Adult Alliance: Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer Report of the Adolescent and Young Adult Oncology Progress Review Group: Report of the Young Adult Oncology Progress Review Group. Bethesda, MD, National Cancer Institute and the Livestrong Young Adult Alliance, NIH Publication No. 06-6067, 2006
6. Tricoli JV, Seibel NL, Blair DG, et al: Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer. J Natl Cancer Inst 103:628-635, 2011
7. Bleyer A: Young adult oncology: The patients and their survival challenges. CA Cancer J Clin 57:242-255, 2007
8. O'Connell JB, Maggard MA, Liu JH, et al: Do young colon cancer patients have worse outcomes? World J Surg 28:558-562, 2004 (Pubitemid 38802791)
9. Zbuk K, Sidebotham EL, Bleyer A, et al: Colorectal cancer in young adults. Semin Oncol 36:439-450, 2009
10. Sargent DJ, Wieand HS, Haller DG, et al: Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: Individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 23:8664-8670, 2005 (Pubitemid 46211509)
11. Sargent D, Shi Q, Yothers G, et al: Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803. Eur J Cancer 47:990-996, 2011
12. Chansky K, Benedetti J, Macdonald JS: Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma. Cancer 103:1165-1171, 2005 (Pubitemid 40328086)
13. O'Connell JB, Maggard MA, Liu JH, et al: Are survival rates different for young and older patients with rectal cancer? Dis Colon Rectum 47:2064-2069, 2004 (Pubitemid 40179066)
14. O'Connell JB, Maggard MA, Livingston EH, et al: Colorectal cancer in the young. Am J Surg 187:343-348, 2004 (Pubitemid 38299499)
15. Bleyer A, Barr R, Hayes-Lattin B, et al: The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 8:288-298, 2008 (Pubitemid 351430865)
16. Gryfe R, Kim H, Hsieh ET, et al: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342:69-77, 2000 (Pubitemid 30036597)
17. Sinicrope FA, Foster NR, Thibodeau SN, et al: DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. J Natl Cancer Inst 103:863-875, 2011
18. LaQuaglia MP, Heller G, Filippa DA, et al: Prognostic factors and outcome in patients 21 years and under with colorectal carcinoma. J Pediatr Surg 27:1085-1089, 1992 (discussion 1889-1890)
19. Chiang JM, Chen MC, Changchien CR, et al: Favorable influence of age on tumor characteristics of sporadic colorectal adenocarcinoma: Patients 30 years of age or younger may be a distinct patient group. Dis Colon Rectum 46:904-910, 2003 (Pubitemid 36875486)
20. Martin S, Ulrich C, Munsell M, et al: Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologist 12:816-824, 2007 (Pubitemid 47328225)